Document is current

Any future updates will be listed below

TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group

Crossref DOI link: https://doi.org/10.1186/s12885-017-3360-z

Published Online: 2017-06-09

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark